Medication as a risk factor for falls: Critical systematic review

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 10, 2007, Pages 1172-1181

  Hartikainen, Sirpa ^a,b   Lönnroos, Eija ^a,c   Louhivuori, Kirsti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Centre for Social and Health Services Kuopio   (Finland)

^c Regional Council of Central Finland   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIAZEPAM; DIURETIC AGENT; FLUOXETINE; FLURAZEPAM; HYPNOTIC AGENT; INOTROPIC AGENT; LORAZEPAM; NEUROLEPTIC AGENT; NITRATE; OPIATE; OXAZEPAM; PAROXETINE; PERIPHERAL VASODILATING AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM;

AGED; CLINICAL TRIAL; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; FALL RISK; FALLING; FRACTURE; HIP FRACTURE; HUMAN; MEDICAL LITERATURE; MEDLINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 35348949020     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.10.1172     Document Type: Review

References (74)

1. Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med. 1994;121:442-451.
2. van Weel C, Vermeulen H, van den Bosch W. Falls: a community care perspective. Lancet. 1995;345:1549-1551.
3. Sattin RW, Lambert Huber DA, DeVito C, et al. The incidence of fall injury events among the elderly in a defined population. Am J Epidemiol. 1990;131:1028-1037.
4. Donald IP, Bulpitt CJ. The prognosis of falls in elderly people living at home. Age Ageing. 1999;28:121-125.
5. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med. 1989;320:1055-1059.
6. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopedic Surgeons Panel on Falls Prevention. J Am Geriat Soc. 2001;49:664-672.
7. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47:30-39.
8. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40-50.
9. Hartikainen S, Rahkonen T, Kautiainen H, et al. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol. 2003;18:163-167.
10. Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809-817.
11. Martin H, Slyk MP, Deymann S, et al. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia. J Am Med Dir Assoc. 2003;4:183-188.
12. Joo JH, Lenze EJ, Mulsant BH, et al. Risk factors for falls during treatment of late-life depression. J Clin Psychiatry. 2002;63:936-941.
13. Nyberg L, Gustafson Y, Janson A, et al. Incidence of falls in three different types of geriatric care. Scand Soc Med. 1997;25:8-13.
14. Koski K, Luukinen H, Laippala P, et al. Physiological factors and medications as predictors of injurious falls by elderly people: a prospective population-based study. Age Ageing. 1996;25:29-38.
15. Souverein PC, Van Staa TP, Egberts ACG, et al. Use of alfa-blockers and the risk of hip/femur fractures. J Intern Med. 2003;254:548-554.
16. Schoofs M, van der Klift M, Hofman A, et al. Thiazide diuretics and risk for hip fracture. Ann Intern Med. 2003;139:476-482.
17. Ivers RQ, Cumming RG, Mitchell P, et al. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc. 1998;46:58-64.
18. Mendelson WB. The use of sedative/hypnotic medication and its correlation with falling down in the hospital. Sleep. 1996;19:698-701.
19. Salgado RI, Lord SR, Ehrlich F, et al. Predictors of falling in elderly hospital patients. Arch Gerontol Geriatr. 2004;38:213-219.
20. Bergland A, Jarnlo GB, Laake K. Predictors of falls in the elderly by location. Aging Clin Exp Res. 2003;15:43-50.
21. Richardson DR, Hicks MJ, Walker RB. Falls in rural elders: an empirical study of risk factors. J Am Board Fam Pract. 2002;15: 178-182.
22. Bueno-Cavanillas A, Padilla-Ruiz F, Jimenez-Moleon JJ, et al. Risk factors in falls among the elderly according to extrinsic and intrinsic precipitating causes. Eur J Epidemiol. 2000;16:849-859.
23. Ensrud EK, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163:949-957.
24. Bae JM, Koo HW, Jung KO. A cohort study on the association between psychotropics and hip fracture in Korean elderly women. J Korean Med Sci. 2002;17:65-70.
25. Stenbacka M, Jansson B, Leifman A, et al. Association between use of sedatives or hypnotics, alcohol consumption, or other risk factors and a single injurious fall or multiple injurious falls: a longitudinal general population study. Alcohol. 2002;28:9-16.
26. Schwartz A, Villa ML, Prill M, et al. Falls in older Mexican-American women. J Am Geriatr Soc. 1999;47:1371-1378.
27. Guo Z, Willis P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148:887-892.
28. Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145-149.
29. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44:217-221.
30. Bergland A, Wyller TB. Risk factors for serious fall related injury in elderly women living in home. Inj Prev. 2004;10:308-313.
31. Katz IR, Rupnow M, Kozma C, et al. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind placebo-controlled trial. Am J Geriatr Psychiatry. 2004;12:499-508.
32. Kallin K, Gustafsson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res. 2004;16: 270-276.
33. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ. 2003;327:712-717.
34. Kelly KD, Pickett W, Yiannakoulias N, et al. Medication use and falls in community-dwelling older persons. Age Ageing. 2003;32:503-509.
35. Ensrud EK, Blackwell T, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629-1637.
36. Rozenfeld S, Camacho LA, Veras P. Medications as a risk factor for falls in older women in Brazil. Rev Panam Salud Publica. 2003;13: 369-375.
37. Hubbard R, Farrington P, Smith C, et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol. 2003;158:77-84.
38. Heitterachi E, Lord SR, Meyerkort P, et al. Blood pressure changes on upright tilting predict falls in older people. Age Ageing. 2002;31: 181-186.
39. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf. 2002;11:97-104.
40. Kallin K, Lundin-Olsson L, Jensen J, et al. Predisposing and precipitating factors for falls among older people in residential care. Public Health. 2002;116:263-271.
41. Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892-898.
42. Wang PS, Bohn RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001;49:1685-1690.
43. Pierfitte C, Macouillard G, Thicoipe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ. 2001;322: 704-708.
44. Tromp AM, Pluijm SMF, Smit JH, et al. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001;54:837-844.
45. Arfken CL, Wilson JG, Aronson SM. Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents. Int Psychogeriatr. 2001;13:85-91.
46. Ray WA, Thapa PB, Gideon P. Benzodiazepines and risk of falls in nursing home residents. J Am Geriatr Soc. 2000;48:682-685.
47. Sgadari A, Lapane KL, Landi F, et al. Oxidative and nonoxidative benzodiazepines and the risk of femur fracture. The Systematic Assessment of Geriatric Drug Use via Epidemiology Study Group. J Clin Psychopharmacol. 2000;20:234-239.
48. Schwab M, Röder F, Aleker T, et al. Psychotropic drug use, falls and hip fractures in the elderly. Aging Clin Exp Res. 2000;12:234-239.
49. Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339:875-882.
50. Chaimowicz F, Ferreira T de J, Miguel DF. Use of psychoactive drugs and related falls among older people living in a community in Brazil. Rev Saude Publica. 2000;34:631-635.
51. Liu B, Anderson G, Mittmann N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351:1303-1307.
52. Kiely DK, Kiel DP, Burrows AB, et al. Identifying nursing home residents at risk for falling. J Am Geriatr Soc. 1998;46:551-555.
53. Nygaard HA. Falls and psychotropic drug consumption in long-term care residents: is there an obvious association? Gerontology. 1998;44: 46-50.
54. Mustard CA, Mayer T. Case-control study of exposure to medication and risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol. 1997;145:738-745.
55. Ebly E, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50:857-863.
56. Graafmans WC, Ooms ME, Hofstee HM, et al. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol. 1996;143:1129-1136.
57. Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996;25:273-278.
58. Thapa PB, Brockman KG, Gideon P, et al. Injurious falls in non-ambulatory nursing home residents: a comparative study of circumstances, incidence, and risk factors. J Am Geriatr Soc. 1996;44: 273-278.
59. World Health Organization (WHO) Guidelines for ATC classification and DDD assignment. WHO collaborating Centre for Drug Statistics Methodology. Oslo, 2003.
60. Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169-1176.
61. Cummings RG, Le Couteur DG. Benzodiazepines and a risk of hip fractures in older people. A review of evidence. CNS Drugs. 2003; 17:825-837.
62. Albercht S, Ihmsen H, Hering W, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999;65:630-639.
63. Kanto J, Kangas L, Aaltonen L, et al. Effect of age on the pharmacokinetics and sedative effects of flunitrazepam. Int J Clin Pharmacol Ther Toxicol. 1981;19:400-404.
64. Stenbach H. The serotonin syndrome. Am J Psychiatry. 1991;148: 705-713.
65. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. Can Med Assoc J. 1996;155:519-527.
66. Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses. 2001;57: 469-471.
67. Maixner SM, Mellow AM, Tandon R. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry. 1999;60: 29-41.
68. Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf. 1997;17:105-118.
69. Ziere G, Dieleman JP, Hofman A, Pols HA, van de Cammen TJ, Stricker BH. Polypharmacy and falls in the middle-aged and elderly population. Br J Clin Pharmacol. 2005;61:218-223.
70. Jyrkkä J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151-158.
71. Nieminen T, Ylitalo R, Kööbi T, et al. The vasodilator effects of alfuzosin and tamsulosin in passive orthostasis: a randomized, double-blind, placebo-controlled study. Eur Urol. 2005;47:340-345.
72. 1-antagonists therapy and occurrence of hypotension-related adverse effects among men with benign prostatic hyperplasia: a retrospective cohort study. Clin Ther. 2001;23:727-743.
73. Hauer K, Lamb SE, Jorstad EC, et al. Systematic review of definitions and methods of measuring falls in randomized controlled fall prevention trials. Age Ageing. 2006;35:5-10.
74. Moore N, Pierfitte C, Pehourcq F, et al. Comparison of patient questionnaire, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther. 2001;69:445-450.